检索结果 - Carol Feghali‐Bostwick

Refine Results
  1. 1
    The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis

    The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis 由 Joe E. Mouawad, Carol Feghali‐Bostwick

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    The Pro-Fibrotic Factor IGFBP-5 Induces Lung Fibroblast and Mononuclear Cell Migration

    The Pro-Fibrotic Factor IGFBP-5 Induces Lung Fibroblast and Mononuclear Cell Migration 由 Hidekata Yasuoka, Yukie Yamaguchi, Carol Feghali‐Bostwick

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    The Mighty Fibroblast and Its Utility in Scleroderma Research

    The Mighty Fibroblast and Its Utility in Scleroderma Research 由 Sara M. Garrett, DeAnna Baker Frost, Carol Feghali‐Bostwick

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Interleukin‐13–producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis

    Interleukin‐13–producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis 由 Patrizia Fuschiotti, Adriana T. Larregina, Johnan Ho, Carol Feghali‐Bostwick, Thomas A. Medsger

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca2+-dependent and regulated by KCa3.1 K+ channels

    Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca2+-dependent and regulated by KCa3.1 K+ channels 由 Katy M. Roach, Carol Feghali‐Bostwick, Heike Wulff, Yassine Amrani, Peter Bradding

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis

    Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis 由 William R. Coward, Keira Watts, Carol Feghali‐Bostwick, Gisli Jenkins, Linhua Pang

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent

    Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent 由 Katy M. Roach, Heike Wulff, Carol Feghali‐Bostwick, Yassine Amrani, Peter Bradding

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators

    IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators 由 Xinh-Xinh Nguyen, Lutfiyya N. Muhammad, Paul J. Nietert, Carol Feghali‐Bostwick

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase‐2 in idiopathic pulmonary fibrosis

    A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase‐2 in idiopathic pulmonary fibrosis 由 William R. Coward, Carol Feghali‐Bostwick, Gisli Jenkins, Alan J. Knox, Linhua Pang

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis

    Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis 由 William R. Coward, Keiria Watts, Carol Feghali‐Bostwick, Alan J. Knox, Linhua Pang

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes

    Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes 由 Christine Peoples, Thomas A. Medsger, Mary Lucas, Bedda L. Rosario, Carol Feghali‐Bostwick

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis

    Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis 由 Ludivine Renaud, Willian A. da Silveira, Naoko Takamura, Gary Hardiman, Carol Feghali‐Bostwick

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Insulin-Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition

    Insulin-Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition 由 Joseph M. Pilewski, Lixin Liu, Adam C. Henry, Alycia V. Knauer, Carol Feghali‐Bostwick

    出版 2005
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy

    Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy 由 Swati Bhattacharyya, Minghua Wu, Feng Fang, Warren G. Tourtellotte, Carol Feghali‐Bostwick, John Varga

    出版 2011
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  15. 15
    A Peptide Derived from Endostatin Ameliorates Organ Fibrosis

    A Peptide Derived from Endostatin Ameliorates Organ Fibrosis 由 Yukie Yamaguchi, Takahisa Takihara, Roger Chambers, Kristen L. Veraldi, Adriana T. Larregina, Carol Feghali‐Bostwick

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis

    Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis 由 Meredith L. Sosulski, Rafael Góngora, Carol Feghali‐Bostwick, Joseph A. Lasky, Cecilia G. Sánchez

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions

    Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions 由 Sara M. Garrett, Eileen Hsu, Justin M. Thomas, Joseph M. Pilewski, Carol Feghali‐Bostwick

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Review: Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis: How Similar and Distinct?

    Review: Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis: How Similar and Distinct? 由 Erica L. Herzog, Aditi Mathur, Andrew M. Tager, Carol Feghali‐Bostwick, Frank Schneider, John Varga

    出版 2014
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  19. 19
    Localized expression of tenascin in systemic sclerosis–associated pulmonary fibrosis and its regulation by insulin‐like growth factor binding protein 3

    Localized expression of tenascin in systemic sclerosis–associated pulmonary fibrosis and its regulation by insulin‐like growth factor binding protein 3 由 Monique L. Brissett, Kristen L. Veraldi, Joseph M. Pilewski, Thomas A. Medsger, Carol Feghali‐Bostwick

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    The K+ Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis

    The K+ Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis 由 Katy M. Roach, S. Mark Duffy, William R. Coward, Carol Feghali‐Bostwick, Heike Wulff, Peter Bradding

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: